## Abstract When isosorbide 5βmononitrate was intravenously infused at a rate of 4 mg h ^β1^ for 2.5 h to five human subjects, its concentrations in plasma increased slowly to 185 ng ml^β1^ Β± 5 per cent C.V. at 2.5 h and a steadyβstate plasma level was not reached during the infusion. When the infu
Pharmacokinetics of oral L-isoidide mononitrate in rats
β Scribed by Tsang-Bin Tzeng; Ho-Leung Fung
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 290 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
L-isoidide mononitrate (L-IIMN) is the most potent mononitrate vasodilator described so far in the literature. Since other mononitrates, such as isosorbide-Smononitrate and isosorbide-2-mononitrate, have been shown not to be subject to first-pass metabolism, we examined the pharmacokinetics of L-IIMN after oral administration to determine whether this compound also exhibited this behavior. An oral dose of 2 mg kg-L-IIMN dissolved in normal saline was given to seven rats. Absorption of L-IIMN after dosing was rapid with an apparent absorption half-life of 9.5 L-3.6 min (mean L-SD). Plasma L-IIMN concentrations peaked between 5 and 20 min after dosing and declined thereafter in an apparently monoexponential manner. The average elimination half-life was 11 -9 & 1.7 min (mean L-SD). Oral bioavailability was estimated to be about 50%. Thus, unlike the other mononitrates so far examined in the literature, L-IIMN exhibits incomplete bioavailability. This pharmacokinetic behavior, however, is consistent with its faster systemic clearance compared to other organic mononitrates.
π SIMILAR VOLUMES
The kinetic behaviour of bovine erythrocyte Cu-Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0.5 to 20mgkg-I. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The
## Abstract The purpose of this study was to compare the hepatic and small intestinal metabolism, and to examine bioavailability and gastroβintestinal firstβpass effects, of kaempferol in rats. Liver and small intestinal microsomes fortified with either NADPH or UDPGA were incubated with varying co
The pharmacokinetics of the anticholinergic drug ethopropazine (ET) have been studied in the rat after intravenous (i.v.) and oral administration. After i.v. doses of 5 and 10 mg/kg ET HCl, mean +/- S.D. plasma AUC were 9836 +/- 2129 (n = 4 rats) and 13096 +/- 4186 ng h/mL (n = 5 rats), respectively